PRKAA2 and pulmonary arterial hypertension: In conclusion, we propose that AMPK couples the inhibition of mitochondrial oxidative phosphorylation to Kv1.5 channel inhibition in pulmonary arterial myocytes, which may contribute to the regulation by AMPK of smooth muscle proliferation and thus to the development of pulmonary hypertension.